IRCT2014071418482N1
Completed
Phase 2
comparison of the effectiveness of adding N-acetylcysteine to current standard treatment with standard treatment alone ??on improving residual renal function in chronic peritoneal and hemodialysis patients
Tehran University of Medical Science0 sites60 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- chronic kidney disease stage 5.
- Sponsor
- Tehran University of Medical Science
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •treating with dialysis for more than 3 months ;having more than 100 mL urine in 24 hours.
Exclusion Criteria
- •treating with dialysis for less than 3 months; having acute renal failure; being currently treated with antioxidants such as vitamins E, C.; being anuric (less than 100 mL urine in 24 hours).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Investigating the efficacy and safety of N-Acetyl Cysteine (NAC) inhalation spray in controlling the symptoms of patients with COVID-19IRCT20080901001165N55Bagheiat-allah University of Medical Sciences250
Completed
Phase 2
Comparing therapeutic efficacy of N-acetyl cysteine with the combination of N-acetyl cysteine and Cimetidine in acute acetaminophen toxicityAcute acetaminophen toxicity.Poisoning by drugs, medicaments and biological substancesT36, T37,IRCT2013102915204N1Vice chancellor for research, Mashhad University of Medical Sciences30
Active, not recruiting
Phase 1
Efficacy and safety of the combination of acetylcysteine, paracetamol and phenylephrine for the treatment of common coldEUCTR2021-002058-96-PLek Pharmaceuticals d.d.1,002
Active, not recruiting
Phase 1
Efficacy and safety of the combination of acetylcysteine, paracetamol and phenylephrine for the treatment of common coldCommon cold and flu-like infectionsMedDRA version: 22.1Level: LLTClassification code 10010106Term: Common coldSystem Organ Class: 100000004862MedDRA version: 20.1Level: LLTClassification code 10000938Term: Acute nasopharyngitis (common cold)System Organ Class: 100000004862Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2021-002058-96-BGek Pharmaceuticals d.d.1,002
Recruiting
Phase 3
Efficacy of N-Acetyl cysteine in patients with autism spectrum disorderAutism spectrum disorder.Childhood autismF84.0IRCT20190714044199N1Medical Science University of Mashhad66